163 related articles for article (PubMed ID: 33411730)
1. Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2.
Shrestha P; Davis DA; Jaeger HK; Stream A; Aisabor AI; Yarchoan R
PLoS Pathog; 2021 Jan; 17(1):e1009091. PubMed ID: 33411730
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
[TBL] [Abstract][Full Text] [Related]
3. CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma.
Patil A; Manzano M; Gottwein E
Blood; 2018 Aug; 132(6):577-586. PubMed ID: 29954751
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma.
Patil A; Manzano M; Gottwein E
Blood Adv; 2019 Jul; 3(14):2105-2117. PubMed ID: 31300418
[TBL] [Abstract][Full Text] [Related]
5. Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide.
Davis DA; Mishra S; Anagho HA; Aisabor AI; Shrestha P; Wang V; Takamatsu Y; Maeda K; Mitsuya H; Zeldis JB; Yarchoan R
Oncotarget; 2017 Aug; 8(31):50342-50358. PubMed ID: 28881567
[TBL] [Abstract][Full Text] [Related]
6. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
7. Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells.
Davis DA; Shrestha P; Aisabor AI; Stream A; Galli V; Pise-Masison CA; Tagawa T; Ziegelbauer JM; Franchini G; Yarchoan R
Oncoimmunology; 2019; 8(2):e1546544. PubMed ID: 30713808
[TBL] [Abstract][Full Text] [Related]
8. CDK4/6 inhibitors sensitize gammaherpesvirus-infected tumor cells to T-cell killing by enhancing expression of immune surface molecules.
Wu Y; Shrestha P; Heape NM; Yarchoan R
J Transl Med; 2022 May; 20(1):217. PubMed ID: 35562811
[TBL] [Abstract][Full Text] [Related]
9. Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease.
Shrestha P; Astter Y; Davis DA; Zhou T; Yuan CM; Ramaswami R; Wang HW; Lurain K; Yarchoan R
Oncoimmunology; 2023; 12(1):2163784. PubMed ID: 36632565
[TBL] [Abstract][Full Text] [Related]
10. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
11. Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomas.
Jaeger HK; Davis DA; Nair A; Shrestha P; Stream A; Yaparla A; Yarchoan R
Sci Rep; 2023 Jul; 13(1):11596. PubMed ID: 37463943
[TBL] [Abstract][Full Text] [Related]
12. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.
Coscoy L; Ganem D
J Clin Invest; 2001 Jun; 107(12):1599-606. PubMed ID: 11413168
[TBL] [Abstract][Full Text] [Related]
13. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
[TBL] [Abstract][Full Text] [Related]
14. Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways.
Granato M; Rizzello C; Gilardini Montani MS; Cuomo L; Vitillo M; Santarelli R; Gonnella R; D'Orazi G; Faggioni A; Cirone M
J Nutr Biochem; 2017 Mar; 41():124-136. PubMed ID: 28092744
[TBL] [Abstract][Full Text] [Related]
15. The intertransmembrane region of Kaposi's sarcoma-associated herpesvirus modulator of immune recognition 2 contributes to B7-2 downregulation.
Kajikawa M; Li PC; Goto E; Miyashita N; Aoki-Kawasumi M; Mito-Yoshida M; Ikegaya M; Sugita Y; Ishido S
J Virol; 2012 May; 86(9):5288-96. PubMed ID: 22379101
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma.
Watanabe T; Nakamura S; Ono T; Ui S; Yagi S; Kagawa H; Watanabe H; Ohe T; Mashino T; Fujimuro M
Biochem Biophys Res Commun; 2014 Aug; 451(1):93-100. PubMed ID: 25063029
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Cellular CpG DNA Methylation by Kaposi's Sarcoma-Associated Herpesvirus.
Journo G; Tushinsky C; Shterngas A; Avital N; Eran Y; Karpuj MV; Frenkel-Morgenstern M; Shamay M
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899086
[TBL] [Abstract][Full Text] [Related]
18. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
19. Arctigenin induces the apoptosis of primary effusion lymphoma cells under conditions of glucose deprivation.
Baba Y; Shigemi Z; Hara N; Moriguchi M; Ikeda M; Watanabe T; Fujimuro M
Int J Oncol; 2018 Feb; 52(2):505-517. PubMed ID: 29207179
[TBL] [Abstract][Full Text] [Related]
20. Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function.
Williamson SJ; Nicol SM; Stürzl M; Sabbah S; Hislop AD
PLoS Pathog; 2016 Nov; 12(11):e1006042. PubMed ID: 27893813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]